{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T15:02:19Z","timestamp":1789398139363,"version":"build-2803163510"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs - Real World Outcomes"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s40801-026-00577-3","type":"journal-article","created":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T14:56:12Z","timestamp":1786546572000},"page":"487-497","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Tolerability, Drug Utilization Pattern and Effectiveness of Minocycline Oral Formulations in India: A Real-World Retrospective Study from Electronic Medical Records"],"prefix":"10.1007","volume":"13","author":[{"given":"Sanjiv","family":"Kandhari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayakar","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Yogiraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakhesh","family":"SV","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rathish T.","family":"Pillai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anupam","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geetanjali","family":"Shetty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pranav","family":"Sheth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhavesh","family":"Lalan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shruti","family":"Dharmadhikari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chintan","family":"Khandhedia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prashant","family":"Devkare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amey","family":"Mane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suyog","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,12]]},"reference":[{"key":"577_CR1","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jgar.2020.01.022","volume":"22","author":"A Asadi","year":"2020","unstructured":"Asadi A, Abdi M, Kouhsari E, Panahi P, Sholeh M, Sadeghifard N, et al. Minocycline: focus on mechanisms of resistance, antibacterial activity, and clinical effectiveness: back to the future. J Glob Antimicrob Resist. 2020;22:161\u201374. https:\/\/doi.org\/10.1016\/j.jgar.2020.01.022.","journal-title":"J Glob Antimicrob Resist"},{"key":"577_CR2","unstructured":"Nazarian S, Akhondi H. Minocycline. In: StatPearls. Treasure Island (FL): StatPearls Publishing. 2025. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK554519\/. Accessed 17 Dec 2025."},{"issue":"7","key":"577_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics10070757","volume":"10","author":"AM Martins","year":"2021","unstructured":"Martins AM, Marto JM, Johnson JL, Graber EM. A review of systemic minocycline side effects and topical minocycline as a safer alternative for treating acne and rosacea. Antibiotics (Basel). 2021;10(7):757. https:\/\/doi.org\/10.3390\/antibiotics10070757.","journal-title":"Antibiotics (Basel)"},{"issue":"4","key":"577_CR4","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/0924-8579(94)90034-5","volume":"4","author":"CD Freeman","year":"1994","unstructured":"Freeman CD, Nightingale CH, Quintiliani R. Minocycline: old and new therapeutic uses. Int J Antimicrob Agents. 1994;4(4):325\u201335. https:\/\/doi.org\/10.1016\/0924-8579(94)90034-5.","journal-title":"Int J Antimicrob Agents"},{"key":"577_CR5","unstructured":"Central Drugs Standard Control Organisation. Drugs database. https:\/\/cdscoonline.gov.in\/CDSCO\/Drugs."},{"key":"577_CR6","doi-asserted-by":"publisher","unstructured":"Kandhari S, Girdhar M, Kulkarni DS, Arsiwala S, Sakhiya J, Karthikeyan K, et al. Expert consensus on the management of acne in India. Int J Res Med Sci. 2022;10(4):980. https:\/\/doi.org\/10.18203\/2320-6012.ijrms20220998","DOI":"10.18203\/2320-6012.ijrms20220998"},{"issue":"8","key":"577_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics14080844","volume":"14","author":"N Madnani","year":"2025","unstructured":"Madnani N, Saraswat A, Nott A, Jakhar D, Gupta LK, Kohli M, et al. PRACT-India: practical recommendations on acne care and medical treatment in India\u2014a modified Delphi consensus. Antibiotics (Basel). 2025;14(8):844. https:\/\/doi.org\/10.3390\/antibiotics14080844.","journal-title":"Antibiotics (Basel)"},{"issue":"5","key":"577_CR8","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1001\/jamadermatol.2024.6542","volume":"161","author":"N Bhatia","year":"2025","unstructured":"Bhatia N, Del Rosso JQ, Stein Gold L, Lain E, Draelos ZD, Sidgiddi S, et al. Efficacy, safety, and tolerability of oral DFD-29, a low-dose formulation of minocycline, in rosacea: two phase 3 randomized clinical trials. JAMA Dermatol. 2025;161(5):499. https:\/\/doi.org\/10.1001\/jamadermatol.2024.6542.","journal-title":"JAMA Dermatol"},{"issue":"2","key":"577_CR9","doi-asserted-by":"publisher","first-page":"76","DOI":"10.4103\/ijdd.ijdd_47_20","volume":"6","author":"S Pande","year":"2020","unstructured":"Pande S, Deshmukh G, Dhoot D, Andhorikar N. Safety and effectiveness of minocycline extended-release versus immediate-release in papulopustular acne: an open-label prospective study. Indian J Drugs Dermatol. 2020;6(2):76\u201380. https:\/\/doi.org\/10.4103\/ijdd.ijdd_47_20.","journal-title":"Indian J Drugs Dermatol."},{"issue":"1","key":"577_CR10","doi-asserted-by":"publisher","first-page":"29","DOI":"10.4103\/0378-6323.125479","volume":"80","author":"A Kanwar","year":"2014","unstructured":"Kanwar A, Parsad D, Mahajan R, Singh A. Effectiveness of dexamethasone oral minipulse therapy versus oral minocycline in active vitiligo vulgaris: randomized controlled study. Indian J Dermatol Venereol Leprol. 2014;80(1):29. https:\/\/doi.org\/10.4103\/0378-6323.125479.","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"11","key":"577_CR11","doi-asserted-by":"publisher","first-page":"629","DOI":"10.3390\/curroncol32110629","volume":"32","author":"PM Ellis","year":"2025","unstructured":"Ellis PM, Long L, Coschi CH, Sathiyapalan A. Strengths and limitations of real-world evidence compared to randomized clinical trials: opportunities in thoracic oncology. Curr Oncol. 2025;32(11):629. https:\/\/doi.org\/10.3390\/curroncol32110629.","journal-title":"Curr Oncol"},{"key":"577_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2024.102915","volume":"78","author":"BE Wilson","year":"2024","unstructured":"Wilson BE, Booth CM. Real-world data: bridging the gap between clinical trials and practice. eClinicalMedicine. 2024;78:102915. https:\/\/doi.org\/10.1016\/j.eclinm.2024.102915.","journal-title":"eClinicalMedicine"},{"issue":"11","key":"577_CR13","doi-asserted-by":"publisher","first-page":"3672","DOI":"10.1111\/jocd.14040","volume":"20","author":"N Shah","year":"2021","unstructured":"Shah N, Shukla R, Chaudhari P, Patil S, Patil A, Nadkarni N, et al. Prevalence and clinico-epidemiological pattern of acne vulgaris in adults: a prospective study. J Cosmet Dermatol. 2021;20(11):3672\u20138. https:\/\/doi.org\/10.1111\/jocd.14040.","journal-title":"J Cosmet Dermatol"},{"key":"577_CR14","doi-asserted-by":"publisher","unstructured":"Budamakuntla L, Parasramani S, Dhoot D, Deshmukh G, Barkate H. Acne in Indian population: an epidemiological study. IP Indian J Clin Exp Dermatol. 2020;6(3):237\u201342. https:\/\/doi.org\/10.18231\/j.ijced.2020.048","DOI":"10.18231\/j.ijced.2020.048"},{"issue":"9","key":"577_CR15","first-page":"26","volume":"13","author":"H Baldwin","year":"2020","unstructured":"Baldwin H. Oral antibiotic treatment options for acne vulgaris. J Clin Aesthet Dermatol. 2020;13(9):26\u201332.","journal-title":"J Clin Aesthet Dermatol."},{"issue":"5","key":"577_CR16","doi-asserted-by":"publisher","first-page":"1006.e1","DOI":"10.1016\/j.jaad.2023.12.017","volume":"90","author":"RV Reynolds","year":"2024","unstructured":"Reynolds RV, Yeung H, Cheng CE, Cook-Bolden F, Desai SR, Druby KM, et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol. 2024;90(5):1006.e1-1006.e30. https:\/\/doi.org\/10.1016\/j.jaad.2023.12.017.","journal-title":"J Am Acad Dermatol"},{"key":"577_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrep.2023.101578","volume":"36","author":"M Vasam","year":"2023","unstructured":"Vasam M, Korutla S, Bohara RA. Acne vulgaris: pathophysiology, treatment, and nanotechnology-based advances. Biochem Biophys Rep. 2023;36:101578. https:\/\/doi.org\/10.1016\/j.bbrep.2023.101578.","journal-title":"Biochem Biophys Rep."},{"issue":"1","key":"577_CR18","doi-asserted-by":"publisher","first-page":"4351","DOI":"10.1038\/s41598-024-55094-6","volume":"14","author":"D Dabash","year":"2024","unstructured":"Dabash D, Salahat H, Awawdeh S, Hamadani F, Khraim H, Koni AA, et al. Prevalence of acne and its impact on quality of life among medical students. Sci Rep. 2024;14(1):4351. https:\/\/doi.org\/10.1038\/s41598-024-55094-6.","journal-title":"Sci Rep"},{"issue":"2","key":"577_CR19","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1111\/bph.12139","volume":"169","author":"N Garrido-Mesa","year":"2013","unstructured":"Garrido-Mesa N, Zarzuelo A, G\u00e1lvez J. Minocycline: far beyond an antibiotic. Br J Pharmacol. 2013;169(2):337\u201352. https:\/\/doi.org\/10.1111\/bph.12139.","journal-title":"Br J Pharmacol"},{"issue":"3","key":"577_CR20","first-page":"425","volume":"145","author":"L Maffeis","year":"2010","unstructured":"Maffeis L, Veraldi S. Minocycline in the treatment of acne: latest findings. G Ital Dermatol Venereol. 2010;145(3):425\u20139.","journal-title":"G Ital Dermatol Venereol"},{"issue":"9","key":"577_CR21","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.69764","volume":"16","author":"N C\u00eerstea","year":"2024","unstructured":"C\u00eerstea N, Radu A, Vesa C, Radu AF, Bungau AF, Tit DM, et al. Treatment adherence in dermatological conditions: strategies to optimize adherence. Cureus. 2024;16(9):e69764. https:\/\/doi.org\/10.7759\/cureus.69764.","journal-title":"Cureus."},{"issue":"12","key":"577_CR22","first-page":"21","volume":"18","author":"AL Rosenberg","year":"2023","unstructured":"Rosenberg AL, Shah M, Del Rosso JQ, Baldwin H, Harper J, Hebert AA, et al. Optimal use and stewardship of oral antibiotics in acne vulgaris: expert consensus. J Clin Aesthet Dermatol. 2023;18(12):21\u20139.","journal-title":"J Clin Aesthet Dermatol."},{"issue":"9","key":"577_CR23","doi-asserted-by":"publisher","first-page":"4274","DOI":"10.3390\/ijerph10094274","volume":"10","author":"CR Lee","year":"2013","unstructured":"Lee CR, Cho IH, Jeong BC, Lee SH. Strategies to minimize antibiotic resistance. Int J Environ Res Public Health. 2013;10(9):4274\u2013305. https:\/\/doi.org\/10.3390\/ijerph10094274.","journal-title":"Int J Environ Res Public Health"}],"container-title":["Drugs - Real World Outcomes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40801-026-00577-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40801-026-00577-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40801-026-00577-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T14:02:28Z","timestamp":1789394548000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40801-026-00577-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,12]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["577"],"URL":"https:\/\/doi.org\/10.1007\/s40801-026-00577-3","relation":{},"ISSN":["2199-1154","2198-9788"],"issn-type":[{"value":"2199-1154","type":"print"},{"value":"2198-9788","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,12]]},"assertion":[{"value":"26 July 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Authors Dr Pranav Sheth, Shruti Dharmadhikari, Dr Chintan Khandhedia, Dr Amey Mane, and Dr Suyog Mehta, are employees of Sun Pharma Laboratories Private Limited. Dr Bhavesh Lalan and Dr Prashant Devkare are employees of Sun Pharmaceutical Industries Limited. Dr Sanjiv Kandhari, Dr Jayakar Thomas, Dr K. Yogiraj, Dr Rakhesh SV, Dr Rathish T. Pillai, Dr Anupam Das, and Dr Geetanjali Shetty do not have any conflict of interest.","order":1,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Royal Pune Independent Ethics Committee (RPIEC 350723) on 27 July 2023. The study was performed in accordance with the standards of ethics outlined in the Declaration of Helsinki.","order":2,"name":"Ethics","label":"Ethical Statement","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}]}}